This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Katholieke Universiteit Leuven, Vib Vzw. Active years: 2014.
Company Filing History:
1 out of 631 
1 out of 237 
Years Active: 2014
Title: Ragna Sannerud: Innovator in Alzheimer's Disease Research
Introduction
Ragna Sannerud is a notable inventor based in Leuven, Belgium. He has made significant contributions to the field of neuroscience, particularly in the context of Alzheimer's disease. His innovative work focuses on the mechanisms underlying this debilitating condition and aims to identify potential therapeutic targets.
Latest Patents
Ragna Sannerud holds a patent titled "Screening methods for compounds that modulate ARF-6 mediated endosomal redistribution." This invention addresses disorders of the peripheral or central nervous system, with a specific emphasis on Alzheimer's disease. The patent outlines methods for screening compounds that can reduce amyloid beta peptide formation in mammalian cells by targeting ARF6 and its effector proteins. This research presents a promising avenue for the prevention and treatment of Alzheimer's disease.
Career Highlights
Throughout his career, Ragna has worked with esteemed organizations such as Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ragna has collaborated with notable colleagues, including Wim Annaert and Katrijn Coen. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Ragna Sannerud's innovative contributions to Alzheimer's disease research highlight the importance of targeting ARF6 in developing new therapeutic strategies. His patent and collaborations reflect a commitment to advancing our understanding of this complex disorder.